- Home
- COLL vs JBI Comparison
COLL vs JBI Comparison
Compare COLL & JBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- JBI
- Stock Information
- Founded
- COLL 2002
- JBI 2002
- Country
- COLL United States
- JBI United States
- Employees
- COLL N/A
- JBI N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- JBI Building Products
- Sector
- COLL Health Care
- JBI Industrials
- Exchange
- COLL Nasdaq
- JBI Nasdaq
- Market Cap
- COLL 1.1B
- JBI 1.2B
- IPO Year
- COLL 2015
- JBI N/A
- Fundamental
- Price
- COLL $45.49
- JBI $5.97
- Analyst Decision
- COLL Strong Buy
- JBI Buy
- Analyst Count
- COLL 5
- JBI 4
- Target Price
- COLL $45.40
- JBI $10.13
- AVG Volume (30 Days)
- COLL 520.4K
- JBI 1.4M
- Earning Date
- COLL 11-06-2025
- JBI 11-06-2025
- Dividend Yield
- COLL N/A
- JBI N/A
- EPS Growth
- COLL N/A
- JBI N/A
- EPS
- COLL 1.63
- JBI 0.34
- Revenue
- COLL $757,067,000.00
- JBI $888,700,000.00
- Revenue This Year
- COLL $21.41
- JBI N/A
- Revenue Next Year
- COLL $3.28
- JBI $3.56
- P/E Ratio
- COLL $28.29
- JBI $17.76
- Revenue Growth
- COLL 26.34
- JBI N/A
- 52 Week Low
- COLL $23.23
- JBI $5.80
- 52 Week High
- COLL $48.18
- JBI $10.80
- Technical
- Relative Strength Index (RSI)
- COLL 74.50
- JBI 13.08
- Support Level
- COLL $35.26
- JBI $5.80
- Resistance Level
- COLL $48.18
- JBI $9.81
- Average True Range (ATR)
- COLL 1.74
- JBI 0.49
- MACD
- COLL 0.93
- JBI -0.32
- Stochastic Oscillator
- COLL 80.20
- JBI 3.70
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About JBI Janus International Group Inc.
Janus International Group Inc is a manufacturer and supplier of turnkey solutions for self-storage, commercial, and industrial building Solutions. The company provides products that include roll-up and swing doors, hallway systems, relocatable storage MASS (Moveable Additional Storage Structures) units, and technologies for automating facility and door operation. It is operated through two geographic regions; Janus North America and Janus International. The Janus International segment is comprised of a subsidiary whose production and sales are largely in Europe and Australia. The Janus North America segment is comprised of all the other entities.